Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients
Research output: Contribution to journal › Journal article › Research › peer-review
Although most patients with gastro-oesophageal reflux disease (GERD) benefit from proton pump inhibitor (PPI) therapy, some experience only partial symptom relief.
| Original language | English |
|---|---|
| Journal | Alimentary Pharmacology and Therapeutics |
| Volume | 36 |
| Issue number | 7 |
| Pages (from-to) | 635-43 |
| Number of pages | 9 |
| ISSN | 0269-2813 |
| DOIs | |
| Publication status | Published - Oct 2012 |
- 2-Pyridinylmethylsulfinylbenzimidazoles, Adult, Esomeprazole Sodium, Esophagitis, Peptic, Female, Gastroesophageal Reflux, Humans, Male, Middle Aged, Omeprazole, Proton Pump Inhibitors, Quality of Life, Randomized Controlled Trials as Topic, Severity of Illness Index, Time Factors, Treatment Outcome
Research areas
ID: 47892467